Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Cocrystal Pharma (COCP) stocks in Canada

Learn how to easily invest in Cocrystal Pharma stocks.

Cocrystal Pharma is a biotechnology business based in the US. Cocrystal Pharma stocks (COCP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.15 – a decrease of 5.4% over the previous week. Cocrystal Pharma employs 13 staff and has a trailing 12-month revenue of around $510,000.

How to buy shares in Cocrystal Pharma

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – COCP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Cocrystal Pharma stock price (NASDAQ:COCP)

Use our graph to track the performance of COCP stocks over time.

Cocrystal Pharma shares at a glance

Information last updated 2022-01-24.
Latest market close$0.50
52-week range$0.47 - $2.29
50-day moving average $0.73
200-day moving average $1.03
Wall St. target price$4.50
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.15

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Cocrystal Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Cocrystal Pharma price performance over time

Historical closes compared with the close of $0.5014 from 2022-01-27

1 week (2022-01-21) -5.38%
1 month (2021-12-25) N/A
3 months (2021-10-29) -43.80%
6 months (2021-07-29) -58.22%
1 year (2021-01-29) -70.85%
2 years (2020-01-28) -35.72%
3 years (2019-01-28) 2.98
5 years (2017-01-27) 28.60%

Cocrystal Pharma financials

Revenue TTM $510,000
Gross profit TTM $-4,293,000
Return on assets TTM -11.03%
Return on equity TTM -18.28%
Profit margin 0%
Book value $0.83
Market capitalisation $47.8 million

TTM: trailing 12 months

Cocrystal Pharma share dividends

We're not expecting Cocrystal Pharma to pay a dividend over the next 12 months.

Have Cocrystal Pharma's shares ever split?

Cocrystal Pharma's shares were split on a 1:30 basis on 24 January 2018. So if you had owned 30 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Cocrystal Pharma shares – just the quantity. However, indirectly, the new 2900% higher share price could have impacted the market appetite for Cocrystal Pharma shares which in turn could have impacted Cocrystal Pharma's share price.

Cocrystal Pharma share price volatility

Over the last 12 months, Cocrystal Pharma's shares have ranged in value from as little as $0.47 up to $2.29. A popular way to gauge a stock's volatility is its "beta".

COCP.US volatility(beta: 0.62)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cocrystal Pharma's is 0.6244. This would suggest that Cocrystal Pharma's shares are less volatile than average (for this exchange).

Cocrystal Pharma overview

Cocrystal Pharma, Inc. , a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase 2a clinical trial to treat HCV infection; and CC-42344, a PB2 inhibitor that is in preclinical development trials for treating influenza infection. It is also involved in identifying and developing non-nucleoside polymerase inhibitors for norovirus infections. Cocrystal Pharma, Inc. has a license and research collaboration agreement with Merck Sharp & Dohme Corp.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site